A detailed history of Globeflex Capital L P transactions in Care Dx, Inc. stock. As of the latest transaction made, Globeflex Capital L P holds 89,148 shares of CDNA stock, worth $1.92 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
89,148
Previous 5,443 1537.85%
Holding current value
$1.92 Million
Previous $84,000 3213.1%
% of portfolio
0.27%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$14.41 - $33.99 $1.21 Million - $2.85 Million
83,705 Added 1537.85%
89,148 $2.78 Million
Q2 2024

Aug 13, 2024

BUY
$7.56 - $16.15 $41,149 - $87,904
5,443 New
5,443 $84,000
Q3 2020

Nov 13, 2020

SELL
$30.88 - $37.94 $359,474 - $441,659
-11,641 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$18.95 - $35.43 $220,596 - $412,440
11,641 New
11,641 $412,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.